BETH MASON ERNST

KEARNEY, NE NPI 1225112014

General Payments — all program years on this page

$5,158.84

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 346
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $599.72 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $599.7220

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,551.02120
2019 $1,112.0782
2020 $472.2822
2021 $532.0942
2022 $449.3328
2023 $442.3332
2024 $599.7220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087847133 Pulmonx Corporation $43.25 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096820351 Novo Nordisk Inc $14.23 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096951140 Novo Nordisk Inc $14.56 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097655901 Novo Nordisk Inc $14.65 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103697062 ABBVIE INC. $14.15 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103697064 ABBVIE INC. $13.33 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103697066 ABBVIE INC. $14.97 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111570883 Amgen Inc. $14.11 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114649794 Exact Sciences Corporation $17.14 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114649800 Exact Sciences Corporation $17.67 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117246867 Amgen Inc. $16.55 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117246869 Amgen Inc. $13.96 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131350161 PFIZER INC. $15.45 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139264650 Astellas Pharma US Inc $18.72 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139277728 Astellas Pharma US Inc $17.23 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141913057 Merck Sharp & Dohme LLC $31.06 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147019128 AIMMUNE THERAPEUTICS, INC. $249.98 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148053208 Inspire Medical Systems, Inc. $27.67 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153509717 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.19 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153631766 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.85 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.